porcin
epidem
diarrhea
viru
pedv
belong
genu
alphacoronaviru
famili
coronaviru
pedv
spheric
diamet
approxim
nm
pedv
singlestrand
positivesens
rna
genom
size
approxim
kb
encod
four
separ
structur
protein
spike
membran
envelop
e
nucleocapsid
n
protein
protein
vital
protein
regul
recognit
interact
specif
cell
receptor
viru
well
induc
neutral
antibodi
gener
protein
howev
essenti
compon
viral
assembl
e
protein
like
facilit
releas
assembl
virion
presenc
e
protein
protein
suffici
format
releas
viruslik
particl
n
protein
essenti
viral
transcript
necessari
format
viruslik
particl
porcin
epidem
diarrhea
ped
first
report
europ
earli
sand
sinc
caus
great
econom
loss
swine
industri
asia
becom
endem
epizoot
asia
recent
decad
caus
mortal
neonat
piglet
howev
diseas
never
occur
american
countri
pedv
emerg
unit
state
sinc
swept
across
north
america
includ
canada
mexico
result
death
million
newborn
piglet
unit
state
alon
epidem
period
pedv
one
devast
viral
diseas
affect
swine
world
caus
signific
financi
effect
global
pork
industri
effect
ped
vaccin
drug
veterinarian
suggest
feedback
materi
fundament
strategi
control
ped
epidem
endem
outbreak
one
import
measur
control
ped
outbreak
vaccin
date
china
inactiv
vaccin
japanes
v
live
vaccin
korea
live
kill
vaccin
oral
live
vaccin
recent
vaccin
candid
engin
replicationdefici
virul
elimin
risk
associ
liveattenu
vaccin
regain
virul
pedv
candid
vaccin
current
develop
includ
spike
protein
nanoparticl
modifi
tobacco
mosaic
viru
tmv
base
fulllength
dna
subunit
protein
induc
neutral
antibodi
pedv
strong
cellular
humor
immun
respons
elicit
vaccin
administ
oral
howev
exist
immun
viral
vector
inactiv
vaccin
safe
product
procedur
simpl
vaccin
elicit
immun
respons
requir
specif
adjuv
liveattenu
vaccin
induc
strong
cellular
humor
immun
respons
risk
virul
revers
viruslik
particl
vlp
compos
one
viral
structur
protein
morpholog
close
resembl
nativ
viru
vlp
risk
revers
virul
elicit
robust
immun
respons
compar
inactiv
liveattenu
viru
vaccin
furthermor
vlp
gener
artifici
method
pathogen
report
merscov
protein
essenti
induc
neutral
antibodi
protein
alon
assembl
vlp
protein
necessari
vlp
composit
e
protein
import
vlp
assembl
thu
pedv
e
protein
necessari
vlp
assembl
via
coexpress
cell
studi
use
baculoviru
express
system
success
construct
recombin
baculoviru
contain
spike
membran
envelop
e
protein
gene
obtain
selfassembl
vlp
infect
cell
recombin
baculoviru
demonstr
structur
integr
vlp
evalu
immunogen
mice
result
establish
foundat
develop
effect
vaccin
pedv
vero
cell
cultur
dmem
gibco
grand
island
usa
cultur
bottl
cell
cultur
tnmfh
medium
sigma
new
york
usa
plate
pedv
gift
professor
hu
guixu
jilin
agricultur
univers
epidem
isol
strain
chosen
pedv
fulllength
e
gene
optim
cell
express
sangon
biotech
optim
e
gene
clone
modifi
pfastbac
dual
plasmid
recombin
plasmid
transform
recombin
bacmid
obtain
bluewhit
spot
screen
previous
describ
indirect
immunofluoresc
assay
perform
determin
whether
desir
protein
express
cell
infect
recombin
baculoviru
method
describ
previous
briefli
infect
cell
cultur
h
fix
precool
paraformaldehyd
min
cell
wash
three
time
pbst
subsequ
cell
incub
mous
polyclon
antibodi
e
pedv
protein
h
next
cell
wash
three
time
pbst
final
cell
incub
fitclabel
goat
antibodi
sigma
ronkonkoma
new
york
usa
mous
igg
contain
evan
blue
h
cell
observ
fluoresc
microscop
three
wash
pbst
construct
recombin
bacmid
contain
e
protein
gene
transfect
cell
postinfect
hpi
desir
recombin
baculoviru
harvest
baculovir
titer
determin
use
bacpak
baculoviru
rapid
titer
kit
clontech
california
usa
determin
inocul
dose
vlp
produc
cultiv
larg
quantiti
cell
infect
recombin
baculoviru
pedv
vlp
harvest
supernat
clear
cell
debri
centrifug
h
supernat
cross
discontinu
sucros
gradient
isol
vlp
procedur
previous
describ
evalu
pedv
vlp
express
perform
modifi
western
blot
assay
harvest
vlp
boil
min
separ
via
sdspage
vlp
gel
transfer
pure
nitrocellulos
blot
nc
membran
ge
healthcar
life
scienc
kent
uk
h
v
membran
block
block
buffer
thermo
massachusett
usa
min
room
temperatur
next
anti
e
mous
polyclon
antibodi
incub
membran
h
membran
wash
three
time
pbst
incub
goat
antimous
iggconjug
hrp
sigma
ronkonkoma
new
york
usa
h
wash
three
time
protein
express
visual
use
ecl
system
thermo
massachusett
usa
pedv
vlp
coactiv
sodium
phosphotungst
min
superflu
prune
away
filter
paper
sampl
examin
use
transmiss
electron
microscopi
sixweekold
femal
balbc
mice
purchas
changchun
anim
breed
center
medic
research
changchun
china
mice
randomli
separ
three
group
micegroup
one
group
immun
purifi
vlp
per
mous
intramuscular
inject
twoweek
interv
second
group
pb
alon
neg
control
last
group
kill
pedv
fig
blood
sampl
collect
everi
week
immun
dispos
method
use
sampl
describ
previous
serum
level
specif
viru
neutral
antibodi
vna
examin
serum
microneutr
sn
assay
use
vero
cell
previous
describ
briefli
serum
sampl
serial
dilut
twofold
dmem
without
serum
incub
h
incub
mix
viru
stock
sampl
mix
vero
cell
h
highest
serum
dilut
cytopath
effect
determin
serumneutr
antibodi
titer
second
week
first
booster
vaccin
red
cell
isol
disrupt
splenocyt
success
separ
wash
twice
medium
gibco
grand
island
usa
contain
fetal
bovin
serum
splenocyt
per
well
cultur
simultan
stimul
inactiv
pedv
elispot
plate
mabtech
stockholm
sweden
incub
h
assay
carri
accord
manufactur
instruct
amount
splenocyt
produc
illustr
spotform
cell
use
elispot
reader
elispot
reader
spectrum
aid
germani
describ
previous
oneway
twoway
anova
use
statist
analysi
p
valu
less
p
deem
display
high
degre
statist
signific
treatment
control
group
modifi
pfastbac
dual
vector
contain
pedv
e
gene
success
construct
fig
allow
us
obtain
recombin
bacmid
pedv
e
gene
express
cell
shown
indirect
immunofluoresc
assay
fig
respect
western
blot
use
prove
vlp
assembl
e
protein
e
band
shown
fig
respect
recombin
baculoviru
express
gene
interest
maintain
transfect
cell
passag
three
time
pedv
vlp
produc
cell
infect
recombin
baculoviru
morpholog
observ
transmiss
electron
microscopi
purifi
pedv
vlp
harvest
use
inconsecut
sucros
gradient
centrifug
studi
tem
shape
size
vlp
similar
viru
fig
shape
vlp
similar
sphere
diamet
approxim
nm
also
spike
protein
around
sphere
fig
neutral
antipedv
antibodi
level
serum
immun
mice
measur
titer
two
week
first
vaccin
vlp
inactiv
pedv
respect
titer
first
booster
vaccin
second
booster
vaccin
fig
contrast
neutral
antipedv
antibodi
detect
mock
group
chang
level
secret
cell
follow
vaccin
analyz
use
elispot
assay
result
show
secret
level
significantli
differ
control
data
shown
contrast
secret
level
significantli
differ
two
group
fig
due
pedv
outbreak
us
studi
pedv
becom
major
goal
anim
virolog
scientist
subsist
commerci
vaccin
current
prevent
infect
piglet
liveattenu
viru
vaccin
often
less
safe
requir
strict
preserv
inactiv
vaccin
safe
use
induc
verylowlevel
immun
respons
therefor
develop
new
vaccin
necessari
studi
baculoviru
express
system
use
produc
pedv
vlp
vlp
structur
antigen
resembl
viru
deriv
serv
effect
standalon
vaccin
vaccin
platform
date
sever
vlpbase
vaccin
produc
commerci
recombin
hepat
b
viru
hbv
human
papillomaviru
hpv
vaccin
human
e
viru
hev
influenza
viru
porcin
circoviru
type
vlp
rsv
noroviru
parvoviru
malaria
also
enter
clinic
studi
mani
viru
vlp
differ
studi
stage
includ
vlp
rabi
hepat
c
viru
hcv
dengu
viru
nipah
viru
bovin
rotaviru
sarscov
merscov
preliminari
result
demonstr
pedv
vlp
success
gener
vlp
consist
elicit
neutral
antibodi
protein
essenti
nucleocapsid
contain
e
protein
appear
obtain
vlp
similar
pedv
thu
vlp
maintain
perfect
immunogen
subunit
vaccin
furthermor
vlp
secur
liveattenu
vaccin
replic
pedvneutr
antibodi
format
induc
vlp
protein
contain
bcellneutr
epitop
protein
contain
conserv
linear
bcell
epitop
elicit
format
protect
antibodi
initi
experi
determin
pedv
vlp
immunogen
mice
high
antipedvneutr
antibodi
level
induc
mice
vaccin
vlp
porcin
model
avail
laboratori
carri
test
pig
studi
foundat
explor
test
whether
vaccin
effect
prevent
pedv
pig
well
known
secret
cell
regul
cellular
immun
respons
secret
cell
mediat
humor
immun
respons
matur
cell
also
inhibit
studi
level
significantli
enhanc
rel
level
howev
level
bare
differ
control
group
demonstr
cell
inhibit
enhanc
level
cellmedi
respons
elicit
pedv
vlp
mention
play
lead
role
protect
pedv
infect
conclus
consist
previou
observ
literatur
suggest
format
antigen
bind
adjuv
consid
differ
adjuv
assess
differ
antigen
format
correspond
differ
complex
format
consequ
stimul
cell
secret
differ
cytokin
elicit
differ
type
immun
respons
immun
respons
primarili
activ
b
cell
specif
antiantigen
antibodi
secret
consequ
relev
pathogen
elimin
host
protect
contrast
bias
immun
respons
caus
immunopatholog
issu
requir
studi
therefor
ideal
vaccin
safe
effect
host
contain
viru
minim
deleteri
effect
vaccin
anim
conclus
studi
develop
pedv
vlp
assembl
viral
e
protein
vlp
superior
immunogen
induc
humor
immun
respons
vaccin
mice
addit
higher
level
specif
virusneutr
antibodi
obtain
believ
vlpbase
vaccin
potenti
prevent
pedv
infect
futur
